Harvard Bioscience
HBIO
A$0.81
Share price
-6.29%
Change (1 day)
-83.13%
Change (1 year)
Categories
Earnings for Harvard Bioscience (HBIO)
Earnings in 2025 (TTM): -A$91.84 Million
According to Harvard Bioscience's latest financial reports the company's current earnings are A$91.39 Million. In 2024 the company made an earning of -A$17.88 Million a decrease over its 2023 earnings that were of -A$3.92 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Harvard Bioscience from 2000 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -A$91.84 Million | 413.65% |
| 2024 | -A$17.88 Million | 356.38% |
| 2023 | -A$3.92 Million | -72.15% |
| 2022 | -A$14.07 Million | 6456.43% |
| 2021 | -A$0.22 Million | -98.08% |
| 2020 | -A$11.18 Million | 32.53% |
| 2019 | -A$8.44 Million | -31.01% |
| 2018 | -A$12.23 Million | 243.9% |
| 2017 | -A$3.56 Million | -24.66% |
| 2016 | -A$4.72 Million | -14.69% |
| 2015 | -A$5.53 Million | -181.68% |
| 2014 | A$6.76 M | -9.97% |
| 2013 | A$7.51 M | 120% |
| 2012 | A$3.41 M | -50.9% |
| 2011 | A$6.96 M | -52.51% |
| 2010 | A$14.65 M | -2.53% |
| 2009 | A$15.03 M | 28.26% |
| 2008 | A$11.72 M | -20.05% |
| 2007 | A$14.66 M | 13.96% |
| 2006 | A$12.86 M | 17.59% |
| 2005 | A$10.94 M | 57.37% |
| 2004 | A$6.95 M | -37.31% |
| 2003 | A$11.09 M | 208.03% |
| 2002 | A$3.6 M | -168.71% |
| 2001 | -A$5.25 Million | -66.89% |
| 2000 | -A$15.83 Million |